Canada Markets open in 34 mins

Constellation Pharmaceuticals, Inc. (CNST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.68+0.83 (+3.34%)
At close: 4:00PM EDT

24.50 -1.18 (-4.60%)
Before hours: 7:02AM EDT

Currency in USD

Valuation Measures

Market Cap (intraday) 51.22B
Enterprise Value 3739.19M
Trailing P/E N/A
Forward P/E 1-8.13
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.58
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-7.39

Trading Information

Stock Price History

Beta (5Y Monthly) 3.29
52-Week Change 3219.00%
S&P500 52-Week Change 3N/A
52 Week High 359.49
52 Week Low 36.01
50-Day Moving Average 328.41
200-Day Moving Average 333.48

Share Statistics

Avg Vol (3 month) 3719.62k
Avg Vol (10 day) 3725.75k
Shares Outstanding 547.5M
Float 33.53M
% Held by Insiders 12.15%
% Held by Institutions 199.53%
Shares Short (Jul. 14, 2020) 44.63M
Short Ratio (Jul. 14, 2020) 45.08
Short % of Float (Jul. 14, 2020) 414.27%
Short % of Shares Outstanding (Jul. 14, 2020) 49.75%
Shares Short (prior month Jun. 14, 2020) 42.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.39%
Return on Equity (ttm)-37.30%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -100.02M
Net Income Avi to Common (ttm)-100.56M
Diluted EPS (ttm)-2.77
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)520.51M
Total Cash Per Share (mrq)10.96
Total Debt (mrq)39.9M
Total Debt/Equity (mrq)8.45
Current Ratio (mrq)19.17
Book Value Per Share (mrq)9.94

Cash Flow Statement

Operating Cash Flow (ttm)-83.13M
Levered Free Cash Flow (ttm)-47.46M